Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2025)
Top medical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Industry: Medical Instruments & Sup...

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Medical is Zen Rated B and is the 42nd ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
NEPH	NEPHROS INC	$5.12	-3.67%	-5.19%	19.35%	19.91%	31.96%	212.20%	387.62%	-18.73%	137.04%	$6.42	$1.39	20.25%	268.35%	0.65	18,800	-71.52%
INFU	INFUSYSTEM HOLDINGS INC	$9.11	-0.22%	-2.46%	-9.71%	-9.80%	50.58%	0.66%	3.29%	-46.06%	206.73%	$11.04	$4.61	17.48%	97.61%	0.88	116,000	-18.88%
NVST	ENVISTA HOLDINGS CORP	$22.10	7.18%	8.07%	10.22%	6.40%	15.46%	10.56%	-32.37%	-31.60%	N/A	$22.68	$14.22	2.56%	55.41%	1.03	4,445,000	69.66%
MMSI	MERIT MEDICAL SYSTEMS INC	$85.42	2.43%	1.34%	-3.29%	-3.80%	-10.24%	-17.70%	15.89%	52.84%	360.98%	$111.45	$78.12	23.36%	9.35%	0.88	458,000	32.75%
KRMD	KORU MEDICAL SYSTEMS INC	$5.89	2.26%	2.97%	50.26%	45.79%	84.06%	49.87%	81.79%	2.97%	1,410.26%	$6.11	$1.86	3.60%	216.67%	0.94	262,000	109.60%
BLCO	BAUSCH & LOMB CORP	$16.74	1.70%	-1.30%	4.82%	11.60%	33.07%	-18.93%	8.98%	N/A	N/A	$18.99	$10.45	11.83%	60.19%	1.08	439,000	176.10%
EMBC	EMBECTA CORP	$11.54	3.87%	-3.43%	-15.58%	-22.91%	13.92%	-42.90%	-65.70%	N/A	N/A	$21.23	$9.20	45.64%	25.43%	0.94	1,017,000	31.23%
ATRC	ATRICURE INC	$41.18	3.68%	13.41%	28.73%	17.16%	23.33%	21.19%	-3.58%	-14.23%	88.73%	$43.11	$28.29	4.48%	45.56%	1.21	731,000	37.66%
HBIO	HARVARD BIOSCIENCE INC	$0.77	6.25%	5.08%	31.67%	70.38%	28.57%	-67.31%	-70.80%	-81.70%	-76.32%	$2.36	$0.28	67.58%	172.24%	1.40	594,000	-50.13%
HAE	HAEMONETICS CORP	$87.16	3.96%	6.41%	23.67%	62.40%	20.82%	3.91%	6.62%	-25.72%	175.65%	$87.32	$47.32	0.18%	84.19%	0.80	1,037,000	18.65%
ANGO	ANGIODYNAMICS INC	$13.32	1.22%	-1.26%	8.47%	21.76%	19.57%	49.83%	6.30%	-9.45%	10.91%	$13.99	$8.27	4.79%	61.06%	1.02	285,000	-5.00%
BAX	BAXTER INTERNATIONAL INC	$18.26	0.55%	-3.34%	2.87%	-23.85%	-42.43%	-41.92%	-65.30%	-76.93%	-51.02%	$37.74	$17.40	51.62%	4.94%	0.63	7,854,000	24.06%
AZTA	AZENTA INC	$36.50	2.53%	2.53%	20.62%	24.66%	19.99%	-21.27%	-39.88%	-49.87%	213.84%	$55.64	$23.91	34.39%	52.66%	1.55	1,187,000	23.39%
WST	WEST PHARMACEUTICAL SERVICES INC	$266.96	0.33%	-6.10%	-3.09%	4.60%	17.24%	-16.38%	10.64%	0.11%	323.48%	$348.90	$187.43	23.49%	42.43%	0.91	684,000	33.33%
LMAT	LEMAITRE VASCULAR INC	$83.66	0.98%	-1.48%	-4.70%	-9.69%	0.04%	-15.84%	77.28%	134.28%	432.19%	$105.55	$71.42	20.74%	17.14%	0.80	279,000	136.44%
RGEN	REPLIGEN CORP	$163.80	1.95%	-1.63%	12.45%	36.24%	23.28%	7.81%	-1.85%	-8.76%	477.17%	$182.52	$102.97	10.26%	59.08%	1.44	580,000	-15.33%
ICUI	ICU MEDICAL INC	$147.59	3.59%	2.46%	6.00%	10.50%	7.90%	-7.82%	-4.88%	-25.02%	34.98%	$175.51	$107.00	15.91%	37.93%	0.99	279,000	55.87%
ISRG	INTUITIVE SURGICAL INC	$555.92	-0.40%	-2.42%	-3.52%	23.54%	4.97%	3.31%	103.01%	120.00%	851.12%	$616.00	$425.00	9.75%	30.80%	1.29	1,563,000	27.07%
BDX	BECTON DICKINSON & CO	$198.40	5.07%	2.50%	9.23%	5.29%	13.77%	-10.40%	-21.91%	-18.13%	28.54%	$251.99	$162.29	21.27%	22.25%	0.47	2,788,000	86.61%
COO	COOPER COMPANIES INC	$80.74	2.84%	6.26%	14.17%	19.33%	11.07%	-18.51%	2.81%	-7.14%	139.34%	$100.24	$61.78	19.45%	30.70%	0.89	3,500,000	-9.75%
STVN	STEVANATO GROUP SPA	$20.85	-2.07%	-10.74%	-14.02%	-19.31%	-15.38%	-2.11%	22.22%	N/A	N/A	$28.00	$17.81	25.54%	17.07%	0.90	264,000	36.08%
WRBY	WARBY PARKER INC	$29.57	27.35%	54.98%	70.04%	9.48%	33.32%	25.67%	78.89%	N/A	N/A	$29.73	$13.63	0.54%	116.95%	1.91	23,552,000	138.24%
BLFS	BIOLIFE SOLUTIONS INC	$24.77	0.08%	-2.90%	-5.78%	-6.49%	3.60%	-5.46%	25.61%	-38.79%	1,020.81%	$29.62	$19.10	16.37%	29.69%	1.86	310,000	30.80%
RMD	RESMED INC	$251.50	2.02%	0.02%	0.56%	-7.01%	-0.46%	2.56%	13.85%	20.49%	351.69%	$293.81	$199.92	14.40%	25.80%	0.83	1,114,000	38.56%
TFX	TELEFLEX INC	$130.50	-0.57%	9.55%	20.87%	0.16%	4.03%	-30.03%	-47.48%	-65.96%	0.76%	$185.94	$102.58	29.82%	27.22%	0.87	1,290,000	-56.96%
ATR	APTARGROUP INC	$117.17	1.25%	-4.01%	0.68%	-14.00%	-23.18%	-31.44%	8.41%	-10.19%	59.57%	$172.60	$103.23	32.11%	13.50%	0.70	525,000	-17.97%
UTMD	UTAH MEDICAL PRODUCTS INC	$56.44	1.42%	1.46%	-1.47%	-7.14%	-1.52%	-11.38%	-43.23%	-39.00%	-0.97%	$65.56	$51.26	13.91%	10.11%	0.56	43,600	215.94%
PDEX	PRO DEX INC	$42.49	1.87%	8.50%	30.62%	19.02%	0.57%	-14.51%	138.91%	4.81%	1,677.82%	$70.26	$23.47	39.52%	81.04%	0.56	22,700	8.10%
ALC	ALCON INC	$80.21	1.96%	0.22%	7.82%	3.02%	-9.83%	-6.53%	14.03%	24.45%	N/A	$99.20	$71.55	19.14%	12.10%	0.83	1,448,000	-4.23%
XRAY	DENTSPLY SIRONA INC	$11.65	4.86%	2.73%	5.91%	-14.96%	-29.01%	-40.41%	-61.83%	-78.46%	-80.86%	$20.60	$9.85	43.43%	18.27%	0.90	4,422,000	23.38%
SMTI	SANARA MEDTECH INC	$24.40	3.26%	15.80%	-13.35%	-27.73%	-18.12%	-33.37%	-33.73%	-40.31%	248.57%	$38.68	$18.90	36.92%	29.10%	1.19	75,000	52.13%
EKSO	EKSO BIONICS HOLDINGS INC	$4.84	0.41%	9.50%	-3.20%	20.70%	16.07%	-52.20%	-77.59%	-93.91%	-99.75%	$14.97	$2.73	67.68%	77.29%	0.81	61,600	-44.50%
BNGO	BIONANO GENOMICS INC	$1.68	1.20%	-2.89%	3.70%	-65.85%	-54.22%	-88.48%	-99.87%	-99.43%	N/A	$22.80	$1.45	92.63%	15.86%	1.89	186,000	8.14%
LUCY	INNOVATIVE EYEWEAR INC	$1.59	8.90%	13.57%	3.25%	-18.04%	-41.97%	-74.02%	-92.10%	N/A	N/A	$7.08	$1.29	77.54%	23.26%	0.97	890,000	755.77%
NNNN	ANBIO BIOTECHNOLOGY	$31.88	-5.56%	-7.66%	83.29%	-30.43%	268.07%	N/A	N/A	N/A	N/A	$55.65	$5.18	42.72%	515.35%	0.28	33,000	-7.04%
FEMY	FEMASYS INC	$0.86	4.35%	-2.92%	-17.02%	140.39%	7.88%	-29.84%	-20.09%	N/A	N/A	$1.80	$0.31	52.06%	181.11%	0.56	1,404,000	13.13%
PLSE	PULSE BIOSCIENCES INC	$14.20	3.73%	5.26%	-7.52%	-3.86%	-18.11%	-14.82%	444.06%	-16.91%	N/A	$25.00	$12.56	43.20%	13.06%	1.37	190,000	31.94%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$24.52	-0.89%	-5.03%	-7.19%	34.80%	19.61%	N/A	N/A	N/A	N/A	$30.00	$13.25	18.27%	85.06%	1.23	299,000	-20.48%
STXS	STEREOTAXIS INC	$2.37	-0.42%	1.72%	-15.05%	-15.66%	0.00%	9.22%	19.10%	-48.48%	144.33%	$3.59	$1.54	33.98%	53.90%	1.16	669,000	167.60%
STSS	SHARPS TECHNOLOGY INC	$2.65	-7.34%	-10.17%	-34.41%	-71.35%	-57.26%	-99.56%	-99.97%	N/A	N/A	$690.00	$2.28	99.62%	16.23%	0.62	301,000	-23.80%
NYXH	NYXOAH SA	$4.92	0.82%	5.24%	-8.38%	-11.67%	-36.92%	-38.25%	-14.58%	N/A	N/A	$11.87	$4.35	58.55%	13.23%	0.42	7,100	-50.69%
GCTK	GLUCOTRACK INC	$6.09	8.36%	5.18%	9.53%	31.53%	-35.35%	-98.22%	-99.94%	-98.83%	-99.87%	$468.00	$4.22	98.70%	44.31%	4.31	844,000	10,583.54%
OSUR	ORASURE TECHNOLOGIES INC	$2.55	3.24%	0.00%	9.44%	-21.78%	-14.72%	-33.07%	-50.58%	-80.37%	-59.39%	$4.22	$2.08	39.57%	22.60%	1.05	882,000	27.46%
MBOT	MICROBOT MEDICAL INC	$2.40	-2.44%	-3.61%	14.83%	-32.77%	-7.69%	140.00%	-42.86%	-66.76%	-99.70%	$4.67	$0.93	48.61%	158.06%	1.30	1,999,000	11.80%
POAI	PREDICTIVE ONCOLOGY INC	$5.92	6.47%	7.44%	-1.66%	-58.46%	-60.13%	-52.52%	-95.20%	-97.33%	-100.00%	$45.90	$3.88	87.10%	52.58%	1.32	49,700	-48.23%
AVR	ANTERIS TECHNOLOGIES GLOBAL CORP	$5.33	12.68%	19.51%	34.77%	10.58%	-0.37%	-4.82%	N/A	N/A	N/A	$8.79	$2.34	39.36%	127.78%	1.80	231,000	58.22%
POCI	PRECISION OPTICS CORPORATION INC	$4.22	-0.94%	-0.71%	0.00%	-2.02%	-9.83%	-19.92%	-28.72%	6.16%	51.25%	$5.34	$3.77	20.97%	12.06%	0.20	11,400	153.33%
RGNT	REGENTIS BIOMATERIALS LTD	$7.10	-5.33%	-5.33%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$7.70	$6.95	7.79%	2.16%	-4.37	4,400	-69.86%
ZJYL	JIN MEDICAL INTERNATIONAL LTD	$0.22	-1.35%	-6.78%	-16.03%	-67.02%	-67.16%	-70.59%	N/A	N/A	N/A	$1.42	$0.22	84.51%	2.33%	1.03	95,000	-22.13%
ZTEK	ZENTEK LTD	$0.72	-2.70%	-4.00%	-9.09%	-18.18%	-50.68%	-34.55%	-58.50%	N/A	N/A	$1.84	$0.62	60.89%	16.13%	0.69	38,200	81.90%
MLSS	MILESTONE SCIENTIFIC INC	$0.34	-2.82%	0.00%	-9.47%	-41.69%	-62.61%	-61.35%	-42.67%	-81.60%	-86.77%	$1.39	$0.28	75.31%	22.42%	1.14	373,000	68.78%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$0.56	-6.06%	-12.81%	-27.53%	-65.56%	-90.33%	N/A	N/A	N/A	N/A	$9.50	$0.55	94.13%	1.45%	0.84	110,000	-39.89%
RVP	RETRACTABLE TECHNOLOGIES INC	$0.82	-0.24%	-0.49%	-2.15%	-0.24%	20.29%	31.51%	-58.27%	-93.26%	-75.44%	$1.14	$0.59	28.25%	38.41%	0.84	11,800	-15.71%
STAA	STAAR SURGICAL CO	$23.99	-5.50%	-9.03%	-12.48%	-13.27%	32.03%	-9.27%	-59.73%	-69.62%	198.01%	$30.81	$13.50	22.14%	77.70%	1.44	2,178,000	-66.49%
NXGL	NEXGEL INC	$1.50	-1.96%	-6.25%	-37.24%	-34.35%	-33.63%	-57.39%	5.34%	N/A	N/A	$5.10	$1.45	70.59%	3.45%	0.84	82,000	222.83%
HOLX	HOLOGIC INC	$74.83	-0.08%	-0.24%	0.71%	14.24%	14.88%	-2.60%	-0.43%	-1.86%	98.12%	$76.29	$51.90	1.91%	44.18%	0.52	2,099,000	12.01%

Medical Stocks FAQ

What are the best medical stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical stocks to buy right now are:

1. Nephros (NASDAQ:NEPH)

Nephros (NASDAQ:NEPH) is the #1 top medical stock out of 56 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Nephros (NASDAQ:NEPH) is: Value: C, Growth: C, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Nephros (NASDAQ:NEPH) has a Due Diligence Score of 53, which is 23 points higher than the medical industry average of 30.

NEPH passed 17 out of 33 due diligence checks and has strong fundamentals. Nephros has seen its stock return 212.2% over the past year, overperforming other medical stocks by 243 percentage points.

Nephros has an average 1 year price target of $6.00, an upside of 17.19% from Nephros's current stock price of $5.12.

Nephros stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Nephros, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Infusystem Holdings (NYSEMKT:INFU)

Infusystem Holdings (NYSEMKT:INFU) is the #2 top medical stock out of 56 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 45, which is 15 points higher than the medical industry average of 30.

INFU passed 14 out of 33 due diligence checks and has strong fundamentals. Infusystem Holdings has seen its stock return 0.66% over the past year, overperforming other medical stocks by 31 percentage points.

Infusystem Holdings has an average 1 year price target of $14.50, an upside of 59.17% from Infusystem Holdings's current stock price of $9.11.

Infusystem Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Infusystem Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Envista Holdings (NYSE:NVST)

Envista Holdings (NYSE:NVST) is the #3 top medical stock out of 56 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Envista Holdings (NYSE:NVST) is: Value: B, Growth: B, Momentum: C, Sentiment: C, Safety: A, Financials: C, and AI: C.

Envista Holdings (NYSE:NVST) has a Due Diligence Score of 33, which is 3 points higher than the medical industry average of 30.

NVST passed 10 out of 33 due diligence checks and has average fundamentals. Envista Holdings has seen its stock return 10.56% over the past year, overperforming other medical stocks by 41 percentage points.

Envista Holdings has an average 1 year price target of $20.88, a downside of -5.54% from Envista Holdings's current stock price of $22.10.

Envista Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Envista Holdings, 25% have issued a Strong Buy rating, 12.5% have issued a Buy, 50% have issued a hold, while 12.5% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 10 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 5.2%, which is 3 percentage points higher than the medical industry average of 2%.

Embecta's dividend payout ratio of 36.6% indicates that its high dividend yield is sustainable for the long-term.

2. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 4.12%, which is 2 percentage points higher than the medical industry average of 2%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -14.6% indicates that its high dividend yield might not be sustainable for the long-term.

3. Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) has an annual dividend yield of 2.79%, which is 1 percentage points higher than the medical industry average of 2%. Baxter International's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Baxter International's dividend has shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of -103% indicates that its dividend yield might not be sustainable for the long-term.

Why are medical stocks up?

Medical stocks were up 1.54% in the last day, and up 0.26% over the last week. Warby Parker was the among the top gainers in the medical instruments & supplies industry, gaining 27.35% yesterday.

Shares of retail companies are trading higher amid overall market strength after the Fed cut rates by 25 basis points.

What are the most undervalued medical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued medical stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued medical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 65 points higher than the medical industry average of 21. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -42.9% in the past year. It has underperformed other stocks in the medical industry by -12 percentage points.

2. Haemonetics (NYSE:HAE)

Haemonetics (NYSE:HAE) is the second most undervalued medical stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Haemonetics has a valuation score of 29, which is 8 points higher than the medical industry average of 21. It passed 2 out of 7 valuation due diligence checks.

Haemonetics's stock has gained 3.91% in the past year. It has overperformed other stocks in the medical industry by 35 percentage points.

3. Becton Dickinson & Co (NYSE:BDX)

Becton Dickinson & Co (NYSE:BDX) is the third most undervalued medical stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Becton Dickinson & Co has a valuation score of 57, which is 36 points higher than the medical industry average of 21. It passed 4 out of 7 valuation due diligence checks.

Becton Dickinson & Co's stock has dropped -10.4% in the past year. It has overperformed other stocks in the medical industry by 20 percentage points.

Are medical stocks a good buy now?

45% of medical stocks rated by analysts are a buy right now. On average, analysts expect medical stocks to rise by 13.86% over the next year.

6.52% of medical stocks have a Zen Rating of A (Strong Buy), 21.74% of medical stocks are rated B (Buy), 50% are rated C (Hold), 13.04% are rated D (Sell), and 8.7% are rated F (Strong Sell).

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 232.49x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2025)
Top medical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Medical Stocks FAQ

1. Nephros (NASDAQ:NEPH)

2. Infusystem Holdings (NYSEMKT:INFU)

3. Envista Holdings (NYSE:NVST)

1. Embecta (NASDAQ:EMBC)

2. Dentsply Sirona (NASDAQ:XRAY)

3. Baxter International (NYSE:BAX)

1. Embecta (NASDAQ:EMBC)

2. Haemonetics (NYSE:HAE)

3. Becton Dickinson & Co (NYSE:BDX)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareMedical Instruments & SuppliesBest Medical Stocks to Buy Now (2025)Top medical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Medical Stocks FAQ

1. Nephros (NASDAQ:NEPH)

2. Infusystem Holdings (NYSEMKT:INFU)

3. Envista Holdings (NYSE:NVST)

1. Embecta (NASDAQ:EMBC)

2. Dentsply Sirona (NASDAQ:XRAY)

3. Baxter International (NYSE:BAX)

1. Embecta (NASDAQ:EMBC)

2. Haemonetics (NYSE:HAE)

3. Becton Dickinson & Co (NYSE:BDX)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2025)
Top medical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.